These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32940235)
1. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis. Kapoor R; So JBY; Zhu F; Too HP; Yeoh KG; Yoong JS Value Health; 2020 Sep; 23(9):1171-1179. PubMed ID: 32940235 [TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk. Zhou HJ; Dan YY; Naidoo N; Li SC; Yeoh KG PLoS One; 2013; 8(12):e83959. PubMed ID: 24386314 [TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607 [TBL] [Abstract][Full Text] [Related]
4. Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysis. Chang HS; Park EC; Chung W; Nam CM; Choi KS; Cho E; Cho WH Asian Pac J Cancer Prev; 2012; 13(6):2721-8. PubMed ID: 22938448 [TBL] [Abstract][Full Text] [Related]
5. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China. Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Kowada A Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581 [No Abstract] [Full Text] [Related]
7. Endoscopic screening for gastric cancer. Dan YY; So JB; Yeoh KG Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306 [TBL] [Abstract][Full Text] [Related]
8. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication. Kowada A Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. So JBY; Kapoor R; Zhu F; Koh C; Zhou L; Zou R; Tang YC; Goo PCK; Rha SY; Chung HC; Yoong J; Yap CT; Rao J; Chia CK; Tsao S; Shabbir A; Lee J; Lam KP; Hartman M; Yong WP; Too HP; Yeoh KG Gut; 2021 May; 70(5):829-837. PubMed ID: 33028667 [TBL] [Abstract][Full Text] [Related]
10. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk. Ascherman B; Oh A; Hur C Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744 [TBL] [Abstract][Full Text] [Related]
11. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States. Shah SC; Canakis A; Peek RM; Saumoy M Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3026-3039. PubMed ID: 32707341 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207 [TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai]. Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584 [No Abstract] [Full Text] [Related]
14. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions. Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189 [TBL] [Abstract][Full Text] [Related]
15. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. Huang HL; Leung CY; Saito E; Katanoda K; Hur C; Kong CY; Nomura S; Shibuya K BMC Med; 2020 Sep; 18(1):257. PubMed ID: 32921305 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170 [TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
18. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597 [TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Ladabaum U; Mannalithara A Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of risk-based breast cancer screening programme, China. Sun L; Legood R; Sadique Z; Dos-Santos-Silva I; Yang L Bull World Health Organ; 2018 Aug; 96(8):568-577. PubMed ID: 30104797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]